Personal CFO Solutions’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-6,317
| Closed | -$111K | – | 474 |
|
2022
Q1 | $111K | Sell |
6,317
-800
| -11% | -$14.1K | 0.02% | 449 |
|
2021
Q4 | $231K | Sell |
7,117
-1,900
| -21% | -$61.7K | 0.04% | 406 |
|
2021
Q3 | $362K | Buy |
9,017
+1,200
| +15% | +$48.2K | 0.07% | 243 |
|
2021
Q2 | $128K | Hold |
7,817
| – | – | 0.03% | 418 |
|
2021
Q1 | $149K | Buy |
7,817
+500
| +7% | +$9.53K | 0.03% | 389 |
|
2020
Q4 | $165K | Sell |
7,317
-1,500
| -17% | -$33.8K | 0.04% | 357 |
|
2020
Q3 | $0 | Buy |
8,817
+1,300
| +17% | – | ﹤0.01% | 254 |
|
2020
Q2 | $157K | Buy |
7,517
+1,100
| +17% | +$23K | 0.05% | 295 |
|
2020
Q1 | $101K | Buy |
+6,417
| New | +$101K | 0.04% | 260 |
|